Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge, Eli Lilly Australia Pty Ltd, CON-1084
Product name
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1084
Standard
Paragraphs 8(1)(f) and (g) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not comply as the product labels do not have the batch and
expiry prefixes immediately preceding the batch and expiry variable data on the
carton and/or container labels.
Therapeutic product type
Prescription medicines